Stay updated on Fulvestrant & Pyrotinib in HR+/HER2+ Clinical Trial

Sign up to get notified when there's something new on the Fulvestrant & Pyrotinib in HR+/HER2+ Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Fulvestrant & Pyrotinib in HR+/HER2+ Clinical Trial page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    12 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.16.1 to version 2.16.2.
    Difference
    0.3%
    Check dated 2025-06-05T11:25:50.000Z thumbnail image
  3. Check
    20 days ago
    Change Detected
    Summary
    The web page has been updated to indicate that the ClinicalTrials.gov data ingest will be modernized in June 2025, and API users can provide input before this change. Additionally, the revision number has been updated from v2.15.2 to v2.16.1.
    Difference
    6%
    Check dated 2025-05-29T06:13:28.000Z thumbnail image
  4. Check
    27 days ago
    No Change Detected
  5. Check
    48 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.
    Difference
    0.3%
    Check dated 2025-04-30T18:04:23.000Z thumbnail image
  6. Check
    62 days ago
    Change Detected
    Summary
    The page has been updated to reflect a new version, changing from v2.14.4 to v2.15.0.
    Difference
    1.0%
    Check dated 2025-04-16T12:44:31.000Z thumbnail image
  7. Check
    70 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.14.3 to version 2.14.4.
    Difference
    0.3%
    Check dated 2025-04-09T05:40:01.000Z thumbnail image
  8. Check
    113 days ago
    Change Detected
    Summary
    The page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.
    Difference
    5%
    Check dated 2025-02-24T20:33:07.000Z thumbnail image

Stay in the know with updates to Fulvestrant & Pyrotinib in HR+/HER2+ Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Fulvestrant & Pyrotinib in HR+/HER2+ Clinical Trial page.